קופגוס

Страна: Ізраїль

мова: іврит

Джерело: Ministry of Health

Активний інгредієнт:

RIBAVIRIN 200 MG

Доступна з:

ROCHE PHARMACEUTICALS (ISRAEL) LTD

Код атс:

J05AB04

Фармацевтична форма:

TABLETS

Адміністрація маршрут:

PER OS

Виробник:

HOFFMANN LA ROCHE, SWITZERLAND

Терапевтична група:

RIBAVIRIN

Терапевтичні свідчення:

Copegus in combination with peginterferon alfa 2a or interferon alfa - 2a is indicated in adult patients who are positive for serum HCV-RNA, including patients with compensated cirrhosis . The combination with peginterferon alfa-2a is also indicated in patients co-infected with clinically stable HIV , including patients with compensated cirrhosis . Copegus, in combination with peginterferon alfa-2a, is indicated in naive patients and patients who have failed previous treatment with interferon alpha (pegylated or non-pegylated) alone or in combination therapy with ribavirin.

Дата Авторизація:

2013-04-01